{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:12:59Z","timestamp":1794103979932,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Brain Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Health economic evaluations support health-care decision-making by providing information on the costs and consequences of health interventions. No universally accepted methodology exists for modelling effectiveness and cost-effectiveness of interventions designed to close treatment gaps for headache disorders in countries of Europe (or elsewhere). Our aim here, within the European Brain Council\u2019s Value-of-Treatment project, was to develop headache-type-specific analytical models to be applied to implementation of structured headache services in Europe as the health-care solution to headache.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed three headache-type-specific decision-analytical models using the WHO-CHOICE framework and adapted these for three European Region country settings (Luxembourg, Russia and Spain), diverse in geographical location, population size, income level and health-care systems and for which we had population-based data. Each model compared current (suboptimal) care vs target care (delivered in accordance with the structured headache services model). Epidemiological and economic data were drawn from studies conducted by the Global Campaign against Headache; data on efficacy of treatments were taken from published randomized controlled trials; assumptions on uptake of treatments, and those made for Healthy Life Year (HLY) calculations and target-care benefits, were agreed with experts. We made annual and 5-year cost estimates from health-care provider (main analyses) and societal (secondary analyses) perspectives (2020 figures, euros).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The analytical models were successfully developed and applied to each country setting. Headache-related costs (including use of health-care resources and lost productivity) and health outcomes (HLYs) were mapped across populations. The same calculations were repeated for each alternative (current vs target care). Analyses of the differences in costs and health outcomes between alternatives and the incremental cost-effectiveness ratios are presented elsewhere.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study presents the first headache-type-specific analytical models to evaluate effectiveness and cost-effectiveness of implementing structured headache services in countries in the European Region. The models are robust, and can assist policy makers in allocating health budgets between interventions to maximize the health of populations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-021-01310-x","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T20:02:55Z","timestamp":1629748975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-4389","authenticated-orcid":false,"given":"Michela","family":"Tinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Paemeleire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimos","family":"Mitsikostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Ruiz","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Brain Council Value of Treatment Headache Working Group, the European Headache Federation, the European Federation of Neurological Associations, and Lifting The Burden: the Global Campaign against Headache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"1310_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and injuries collaborators","year":"2020","unstructured":"GBD 2019 Diseases and injuries collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 396:1204\u20131222","journal-title":"Lancet"},{"issue":"1","key":"1310_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z, on behalf of Lifting The Burden: the Global Campaign against Headache (2020) Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21(1):137. https:\/\/doi.org\/10.1186\/s10194-020-01208-0","journal-title":"J Headache Pain"},{"key":"1310_CR3","unstructured":"Institute for Health Metrics and Evaluation (2020) At: http:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/headache-disorders-level-3-cause [Accessed 13 Dec 2020]"},{"issue":"10100","key":"1310_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, Aboyans V, Abu-Raddad LJ, Ackerman IN, Adamu AA, Adetokunboh O, Afarideh M, Afshin A, Agarwal SK, Aggarwal R, Agrawal A, Agrawal S, Ahmadieh H, Ahmed MB, Aichour MTE, Aichour AN, Aichour I, Aiyar S, Akinyemi RO, Akseer N, Al Lami FH, Alahdab F, Al-Aly Z, Alam K, Alam N, Alam T, Alasfoor D et al (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 390(10100):1211\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"issue":"11","key":"1310_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"LJ Stovner","year":"2018","unstructured":"Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, Ansha MG, Barac A, Bensenor IM, Doan LP, Edessa D, Endres M, Foreman KJ, Gankpe FG, Gururaj G, Goulart AC, Gupta R, Hankey GJ, Hay SI, Hegazy MI, Hilawe EH, Kasaeian A, Kassa DH, Khalil I, Khang Y-H, Khubchandani J, Kim YJ, Kokubo Y, Mohammed MA, Moradi-Lakeh M, Nguyen HLT, Nirayo YL, Qorbani M, Ranta A, Roba KT, Safiri S, Santos IS, Satpathy M, Sawhney M, Shiferaw MS, Shiue I, Smith M, Szoeke CEI, Truong NT, Venketasubramanian N, Weldegwergs KG, Westerman R, Wijeratne T, Xuan Tran B, Yonemoto N, Feigin VL, Vos T, Murray CJL (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 17(11):954\u2013976. https:\/\/doi.org\/10.1016\/S1474-4422(18)30322-3","journal-title":"Lancet Neurol"},{"key":"1310_CR6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and injury incidence and prevalence collaborators","year":"2018","unstructured":"GBD 2017 Disease and injury incidence and prevalence collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study. Lancet 392:1789\u20131858","journal-title":"Lancet"},{"issue":"5","key":"1310_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","volume":"19","author":"M Linde","year":"2012","unstructured":"Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barr\u00e9 J, Katsarava Z, Lainez JM, Lampl C, Lant\u00e9ri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andr\u00e9e C (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703\u2013711. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03612.x","journal-title":"Eur J Neurol"},{"key":"1310_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","volume":"20","author":"TJ Steiner","year":"2019","unstructured":"Steiner TJ, Jensen R, Katsarava Z, Linde M, EA MG, Osipova V, Paemeleire K, Olesen J, Peters M, Martelletti P, on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache (2019) Aids to management of headache disorders in primary care (2nd edition). J Headache Pain 20:57","journal-title":"J Headache Pain"},{"key":"1310_CR9","doi-asserted-by":"crossref","unstructured":"Steiner TJ, Jensen R, Katsarava Z, Stovner LJ, Uluduz D, Adarmouch L, Al Jumah M, Al Khathaami AM, Ashina M, Braschinsky M, Broner S, Eliasson JH, Gil-Gouveia R, G\u00f3mez-Galv\u00e1n JB, Gu\u00f0mundsson LS, Herekar AA, Kawatu N, Kissani N, Kulkarni GB, Lebedeva ER, Leonardi M, Linde M, Luvsannorov O, Maiga Y, Milanov I, Mitsikostas DD, Musayev T, Olesen J, Osipova V, Paemeleire K, Peres MFP, Quispe G, Rao GN, Risal A, Ruiz de la Torre E, Saylor D, Togha M, Yu SY, Zebenigus M, Zenebe Zewde Y, Zidverc-Trajkovi\u0107 J, Tinelli M on behalf of Lifting The Burden: the Global Campaign against Headache (2021). Structured headache services as the solution to the ill-health burden of headache. 1. Rationale and description. J headache pain (details to be added in proof)","DOI":"10.1186\/s10194-021-01265-z"},{"issue":"1","key":"1310_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19(1):17. https:\/\/doi.org\/10.1186\/s10194-018-0846-2","journal-title":"J Headache Pain"},{"key":"1310_CR11","first-page":"718","volume":"21","author":"A Gustavasson","year":"2011","unstructured":"Gustavasson A, Svensson M, Jacobi F (2011) Cost of disorders of the brain in Europe 2010. Eur Psychopharmacology 21:718\u2013779","journal-title":"Eur Psychopharmacology"},{"issue":"6","key":"1310_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.neuron.2014.05.044","volume":"82","author":"M DiLuca","year":"2014","unstructured":"DiLuca M, Olesen J (2014) The cost of brain diseases: a burden or a challenge? Neuron 82(6):1205\u20131208. https:\/\/doi.org\/10.1016\/j.neuron.2014.05.044","journal-title":"Neuron"},{"key":"1310_CR13","volume-title":"The value of treatment project. Policy white paper","author":"European Brain Council","year":"2017","unstructured":"European Brain Council (2017) The value of treatment project. Policy white paper. Available at: http:\/\/www.braincouncil.eu\/activities\/projects\/value-of-treatment-policy-white-paper [Accessed 13 Dec 2020]"},{"issue":"S1","key":"1310_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10072-018-3366-6","volume":"39","author":"M Leonardi","year":"2018","unstructured":"Leonardi M, Ruiz De La Torre E, Steiner T, Tinelli M, Raggi A, D\u2019Amico D, Grazzi L, Paemeleire K, Mitsikostas D (2018) Value of treatment of headache patients and need to improve headache patients\u2019 journey. Neurol Sci 39(S1):115\u2013116. https:\/\/doi.org\/10.1007\/s10072-018-3366-6","journal-title":"Neurol Sci"},{"key":"1310_CR15","doi-asserted-by":"publisher","unstructured":"Tinelli M, Leonardi M, Paemeleire K, et al. Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions. J Headache Pain. 2021;22:90. https:\/\/doi.org\/10.1186\/s10194-021-01305-8.","DOI":"10.1186\/s10194-021-01305-8"},{"issue":"1","key":"1310_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1129-2377-15-31","volume":"15","author":"TJ Steiner","year":"2014","unstructured":"Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lant\u00e9ri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Barr\u00e9 J, Andr\u00e9e C (2014) The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 15(1):31. https:\/\/doi.org\/10.1186\/1129-2377-15-31","journal-title":"J Headache Pain"},{"issue":"5","key":"1310_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/0333102412438977","volume":"32","author":"I Ayzenberg","year":"2012","unstructured":"Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ (2012) The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32(5):373\u2013381. https:\/\/doi.org\/10.1177\/0333102412438977","journal-title":"Cephalalgia"},{"issue":"5","key":"1310_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/ene.12380","volume":"21","author":"I Ayzenberg","year":"2014","unstructured":"Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Steiner TJ (2014) Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol 21(5):758\u2013765. https:\/\/doi.org\/10.1111\/ene.12380","journal-title":"Eur J Neurol"},{"issue":"1","key":"1310_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s10194-015-0496-6","volume":"16","author":"M Linde","year":"2015","unstructured":"Linde M, Steiner TJ, Chisholm D (2015) Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. J Headache Pain 16(1):15. https:\/\/doi.org\/10.1186\/s10194-015-0496-6","journal-title":"J Headache Pain"},{"issue":"1","key":"1310_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s10194-018-0839-1","volume":"19","author":"Z Katsarava","year":"2018","unstructured":"Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ (2018) Poor medical care for people with migraine in Europe - evidence from the Eurolight study. J Headache Pain 19(1):10. https:\/\/doi.org\/10.1186\/s10194-018-0839-1","journal-title":"J Headache Pain"},{"issue":"3","key":"1310_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","volume":"27","author":"LJ Stovner","year":"2007","unstructured":"Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193\u2013210. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01288.x","journal-title":"Cephalalgia"},{"key":"1310_CR22","unstructured":"http:\/\/www.worldometers.info [Accessed 13 Dec 2020]"},{"key":"1310_CR23","unstructured":"http:\/\/data.worldbank.org [Accessed 13 Dec 2020]"},{"key":"1310_CR24","series-title":"Global Health Estimates Technical Paper WHO\/HIS\/IER\/GHE\/2017.1","volume-title":"WHO methods and data sources for global burden of disease estimates 2000\u20132015","author":"WHO","year":"2017","unstructured":"WHO. WHO methods and data sources for global burden of disease estimates 2000\u20132015. (2017) Global Health Estimates Technical Paper WHO\/HIS\/IER\/GHE\/2017.1 https:\/\/www.who.int\/healthinfo\/global_burden_disease\/GlobalDALYmethods_2000_2015.pdf [Accessed 5 Oct 2020]"},{"key":"1310_CR25","volume-title":"WHO-CHOICE (CHOosing interventions that are cost-effective) project","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014) WHO-CHOICE (CHOosing interventions that are cost-effective) project. WHO, Geneva Available at: https:\/\/www.who.int\/choice\/cost-effectiveness\/en\/ [Accessed 13 Dec 2020]"},{"issue":"4","key":"1310_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3109\/15360280903328185","volume":"23","author":"J Yu","year":"2009","unstructured":"Yu J, Goodman MJ, Oderda GM (2009) Economic evaluation of pharmacotherapy of migraine pain: a review of the literature. J Pain Palliat Care Pharmacother 23(4):396\u2013408. https:\/\/doi.org\/10.3109\/15360280903328185","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"1310_CR27","unstructured":"http:\/\/www.wageindicator.org\/main\/salary\/Salarycheckers [Accessed 13 Dec 2020]"},{"key":"1310_CR28","unstructured":"European Central Bank. Statistical Data Warehouse. Eurosystem. http:\/\/sdw.ecb.europa.eu\/ [Accessed 5 Oct 2020]"},{"key":"1310_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s10194-016-0599-8","volume":"17","author":"C Lampl","year":"2016","unstructured":"Lampl C, Thomas H, Stovner LJ, Tassorelli C, Katsarava Z, JMA L, Lant\u00e9ri-Minet M, Rastenyte D, de la Ruiz Torre E, Andr\u00e9e C, Steiner TJ (2016) Interictal burden attributable to episodic headache: findings from the Eurolight project. J Headache Pain 17:9","journal-title":"J Headache Pain"},{"key":"1310_CR30","doi-asserted-by":"crossref","unstructured":"Steiner TJ, Linde M, Schnell-Inderst P (2021) A universal outcome measure for headache treatments, care-delivery systems and economic analysis. J Headache Pain (details to be added in proof)","DOI":"10.1186\/s10194-021-01269-9"},{"key":"1310_CR31","first-page":"CD008041","volume":"4","author":"V Kirthi","year":"2010","unstructured":"Kirthi V, Derry S, Moore RA (2010) Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD008041","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1310_CR32","first-page":"CD008615","volume":"2","author":"CJ Derry","year":"2012","unstructured":"Derry CJ, Derry S, Moore RA (2012) Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2(2):CD008615","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1310_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.clinthera.2009.03.020","volume":"31","author":"DW Dodick","year":"2009","unstructured":"Dodick DW, Freitag F, Banks J (2009) Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther 31(3):542\u2013559. https:\/\/doi.org\/10.1016\/j.clinthera.2009.03.020","journal-title":"Clin Ther"},{"key":"1310_CR34","first-page":"CD011889","volume":"6","author":"G Stephens","year":"2016","unstructured":"Stephens G, Derry S, Moore RA (2016) Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev 6:CD011889","journal-title":"Cochrane Database Syst Rev"},{"key":"1310_CR35","volume-title":"Luxembourg: Country Health Profile 2017. In series: State of Health in the EU","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Luxembourg: Country Health Profile 2017. In series: State of Health in the EU (2017). Available at: http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0011\/355988\/Health-Profile-Luxembourg-Eng.pdf?ua=1 [Accessed 13 Dec 2020]"},{"issue":"5","key":"1310_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10194-011-0356-y","volume":"12","author":"C Andr\u00e9e","year":"2011","unstructured":"Andr\u00e9e C, Stovner LJ, Steiner TJ, Barre J, Katsarava Z, Lainez JM, Lair M-L, Lanteri-Minet M, Mick G, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Vriezen P, Lampl C (2011) The Eurolight project: the impact of primary headache disorders in Europe. Description of methods. J Headache Pain 12(5):541\u2013549. https:\/\/doi.org\/10.1007\/s10194-011-0356-y","journal-title":"J Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-021-01310-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T20:03:12Z","timestamp":1629748992000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-021-01310-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1186\/s10194-021-01310-x","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Ethics approval was not needed for these economic analyses supported by published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}